| Lindsey N Kerrey, | |
|
7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 | |
| (402) 717-0070 | |
| (402) 717-0073 |
| Full Name | Lindsey N Kerrey |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 7710 Mercy Rd Ste 3000, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013429026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 2012 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in Texas to offer this total heart replacement.
Researchers at North Carolina State University have developed a mathematical model for computing radiation therapy treatments that could substantially reduce patient side effects while delivering the same results as conventional radiation therapy.
A new case report in the Journal of the Endocrine Society documents how a patient's use of a common biotin supplement, also known as vitamin B7, caused her to have clinically misleading test results, which prompted numerous consultations and unnecessary radiographic and laboratory testing.
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.
The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.
› Verified 1 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in Texas to offer this total heart replacement.
Researchers at North Carolina State University have developed a mathematical model for computing radiation therapy treatments that could substantially reduce patient side effects while delivering the same results as conventional radiation therapy.
A new case report in the Journal of the Endocrine Society documents how a patient's use of a common biotin supplement, also known as vitamin B7, caused her to have clinically misleading test results, which prompted numerous consultations and unnecessary radiographic and laboratory testing.
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.
The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey N Kerrey, 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: (402) 398-6248 | Lindsey N Kerrey, 7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 Ph: (402) 717-0070 |
News Archive
A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in Texas to offer this total heart replacement.
Researchers at North Carolina State University have developed a mathematical model for computing radiation therapy treatments that could substantially reduce patient side effects while delivering the same results as conventional radiation therapy.
A new case report in the Journal of the Endocrine Society documents how a patient's use of a common biotin supplement, also known as vitamin B7, caused her to have clinically misleading test results, which prompted numerous consultations and unnecessary radiographic and laboratory testing.
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.
The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.
› Verified 1 days ago
Jacqueline Maria Sellner, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 13609 California Street, Suite 200, C/o Aureus Medical Group, Omaha, NE 68154 Phone: 800-856-6385 | |
Carrie L Hovey, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4920 S 30th St, Suite 103, Omaha, NE 68107 Phone: 402-734-4110 Fax: 402-734-3990 | |
Ms. Gloria Kokes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2429 M St, Omaha, NE 68107 Phone: 402-731-7333 Fax: 402-614-5405 | |
Angela Salazar, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4920 S 30th St Ste 103, Omaha, NE 68107 Phone: 402-734-4110 Fax: 402-734-3990 | |
Sandra M Cayler, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2126 N 117th Ave, Omaha, NE 68164 Phone: 402-934-1617 Fax: 402-934-5228 | |
Nicole M Shaffer, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 224, Omaha, NE 68124 Phone: 402-717-0880 Fax: 402-717-6068 | |
Olivia B Tedesco, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6014 Fax: 402-398-6983 |